TITLE

Increased hepatic platelet activating factor (PAF) and PAF receptors in carbon tetrachloride induced liver cirrhosis

AUTHOR(S)
Yang, Y.; Nemoto, E. M.; Harvey, S. A. K.; Subbotin, V. M.; Gandhi, C. R.
PUB. DATE
June 2004
SOURCE
Gut;Jun2004, Vol. 53 Issue 6, p877
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background and aims: The liver is a major site for the synthesis and actions of platelet activating factor (PAF), a potent hepatic vasoconstrictor and systemic vasodilator. As PAF is implicated in portal hypertension and hyperdynamic circulation associated with liver cirrhosis, we characterised changes in the hepatic PAF system in experimental cirrhosis. Methods: In rats made cirrhotic by carbon tetrachloride (CCl4) administration for eight weeks, we determined hepatic levels of PAF and its cognate receptor, and the effects of PAF and PAF antagonist (BN52021) on portal and arterial pressure. Results: Compared with control rats, cirrhotic rats had higher hepatic PAF levels, higher apparent hepatic efflux of PAF, and higher PAF levels in arterial blood (p<0.01, p<0.01, p<0.05, respectively). Relative to controls, cirrhotic livers had elevated hepatic PAF receptors (by mRNA and protein levels and [3H]PAF binding), higher (p<0.01) baseline hepatic portal pressure, and an augmented (p = 0.03) portal pressure response to PAF infusion (1 μ/kg). Portal infusion of BN52021 (5 mg/kg) showed that elevated endogenous PAF was responsible for 23% of the cirrhotic portal pressure increase but made no contribution to systemic hypotension. Finally, increased PAF receptor density was observed in the contractile perisinusoidal stellate cells isolated from cirrhotic livers relative to those from control livers. Conclusions: In cirrhosis, increased hepatic release of PAF elevates systemic PAF; in combination with upregulated hepatic PAF receptors in stellate cells, this contributes to portal hypertension.
ACCESSION #
13354306

 

Related Articles

  • Hepatic stellate cells may be potential effectors of platelet activating factor induced portal hypertension. Yan Chen; Chun-Ping Wang; Yin-Ying Lu; Lin Zhou; Shu-Hui Su; Hong-Jun Jia; Yong-Yi Feng; Yong-Ping Yang // World Journal of Gastroenterology;1/14/2008, Vol. 14 Issue 2, p218 

    AIM: To determine platelet activating factor (PAF) receptor expression in cirrhotic hepatic stellate cells. METHODS: Hepatic stellate cells, isolated from the livers of control and CCl4-induced cirrhotic rats, were placed in serum-free medium after overnight culture. We determined the PAF...

  • Synthesis of platelet-activating factor and its receptor expression in Kupffer cells in rat carbon tetrachloride-induced cirrhosis. Yin-Ying Lu; Chun-Ping Wang; Lin Zhou; Yan Chen; Shu-Hui Su; Yong-Yi Feng; Yong-Ping Yang; Kremer, Michael // World Journal of Gastroenterology;2/7/2008, Vol. 14 Issue 5, p764 

    AIM: To determine the platelet-activating factor (PAF) synthesis and its receptor expression in Kupffer cells in rat carbon tetrachloride-induced cirrhosis. METHODS: Kupffer cells, isolated from the livers of control and CCl4-induced cirrhotic rats, were placed in serum-free medium overnight....

  • Effect of early propranolol administration on portal hypertensive gastropathy in cirrhotic rats. Rafailidis, Savas; Demertzidis, Charalampos; Ballas, Konstantinos; Alatsakis, Michail; Symeonidis, Nikolaos; Pavlidis, Theodoros; Psarras, Kyriakos; Tzioufa-Asimakopoulou, Valentini; Sakadamis, Athanassios; Snyder, Ned; Ozdogan, Osman C.; Sun-Lung Tsai // World Journal of Gastroenterology;9/14/2009, Vol. 15 Issue 34, p4284 

    AIM: To investigate any protective effect of early propranolol administration in the development of portal hypertensive gastropathy in cirrhotic rats. METHODS: For the development of liver cirrhosis and portal hypertensive gastropathy, 60 rats underwent ligation of the left adrenal vein and...

  • Hemodynamic Effects of the Non-Peptidic Angiotensin-(1-7) Agonist AVE0991 in Liver Cirrhosis. Klein, Sabine; Herath, Chandana B.; Schierwagen, Robert; Grace, Josephine; Haltenhof, Tom; Uschner, Frank E.; Strassburg, Christian P.; Sauerbruch, Tilman; Walther, Thomas; Angus, Peter W.; Trebicka, Jonel // PLoS ONE;9/25/2015, Vol. 10 Issue 9, p1 

    Background & Aims: Although in cirrhosis with portal hypertension levels of the vasoconstrictor angiotensin II are increased, this is accompanied by increased production of angiotensin (Ang)-(1–7), the endogenous ligand of the Mas receptor (MasR), which blunts hepatic fibrosis and...

  • Effect of early bosentan administration on the development of esophageal varices in cirrhotic rats: experimental study in Wistar rats. Rafailidis, Savas; Ballas, Konstantinos; Psarras, Kyriakos; Pavlidis, Theodoros; Emoniotou, Eleni; Papamichali, Rodoula; Kalodimos, Georges; Marakis, Georges; Sakadamis, Athanassios; Koukoulis, Georges // Journal of Gastroenterology;2008, Vol. 43 Issue 11, p897 

    This study was conducted to investigate the effect of chronic bosentan administration on the development of esophageal varices in carbon tetrachloride-induced cirrhosis in rats. For the development of liver cirrhosis and esophageal varices, 60 rats underwent ligation of the left adrenal vein,...

  • Low NO bioavailability in CCl4 cirrhotic rat livers might result from low NO synthesis combined with decreased superoxide dismutase activity allowing superoxide-mediated NO breakdown: A comparison of two portal hypertensive rat models with healthy controls. Van de Casteele, Marc; Van Pelt, Jos F.; Nevens, Frederik; Reichen, Jürg; Fevery, Johan // Comparative Hepatology;2003, Vol. 2, p1 

    Background: In cirrhotic livers, the balance of vasoactive substances is in favour of vasoconstrictors with relatively insufficient nitric oxide. Endothelial dysfunction has been documented in cirrhotic rat livers leading to a lower activity of endothelial nitric oxide synthase but this might...

  • Lamifiban: A Viewpoint by David J. Moliterno. Moliterno, D.J. // Drugs;Feb1999, Vol. 57 Issue 2, p222 

    Comments on lamifiban, one of the most potent members of the small-molecule class of IIb/IIIa inhibitors developed for intravenous administration. Kinetics which make lamifiban's antiplatelet effect highly dependent on renal function; Antiplatelet effect of peptidomimetrics; Benefits from...

  • Protective effects of roasted coffee drink on liver function of cirrhotic rats. Neto, Youssef A. H.; Rocha, Bruno A.; Pedroso, Rodrigo N.; Neto, Marthus M. F .; Paula, Fernanda B. A.; Duarte, Stella M. S. // Journal of Natural Pharmaceuticals;Dec2010, Vol. 1 Issue 1, p19 

    The role of oxidative stress as a major cause of tissue injury has been suggested and it has been demonstrated that changes in the oxidant and antioxidant mechanisms contribute largely to hepatic necrosis in these situations. However, the increased intake of foods rich in antioxidants could help...

  • Restrictive model of compensated carbon tetrachloride-induced cirrhosis in rats. Regimbeau, Jean-Marc; Fuks, David; Kohneh-Shahri, Niaz; Terris, Benoît; Soubrane, Olivier // World Journal of Gastroenterology;12/7/2008, Vol. 14 Issue 45, p6943 

    AIM: To develop a simplified and quick protocol to induce cirrhosis and standardize models of partial liver resection in rats. METHODS: In Fischer F344 rats two modified protocols of phénobarbital-carbon tetrachloride (CCI4) (dilution 50%) gavage to induce cirrhosis (frequency adjusted...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics